• Clinigen's ALS therapy bags US orphan status pharmatimes
    July 14, 2020
    ALS is a severe, neurodegenerative disease which affects motor neurons leading to progressive muscle weakness, paralysis and ultimately death within a median time of two to four years from disease onset.
PharmaSources Customer Service